Sign in

Stephanie L. Graff, MD FACP FASCO

@drsgraff.bsky.social
1.9K followers 214 following 175 posts

Director Breast Oncology, Brown University Health Cancer Institute, Legorreta Cancer Center Brown Univ| #bcsm #clinicaltrials #oncology | Views Mine

PostsRepliesMedia
Stephanie L. Graff, MD FACP FASCO @drsgraff.bsky.social · 29/08/2025
“In giving, we are connected. Gifts speak for us when the weight of emotion and the vulnerability of truth are too much.” Brown Paper Bags | Journal of Clinical Oncology ascopubs.org/doi/10.1200/...
ascopubs.org
Brown Paper Bags
130
Stephanie L. Graff, MD FACP FASCO @drsgraff.bsky.social · 24/06/2025
“Who decides who decides?” Partnered w/ @shrutipatelmd.bsky.social on this editorial from Dr. Campbell & @laurabukavinamd.bsky.social work in which we explore how altmetrics & digital clout are shaped by systemic bias #MedSky #WomenInMedicine ascopubs.org/doi/10.1200/...
ascopubs.org
Invisible in the Metrics of Academic Oncology | JCO Oncology Practice
032
Stephanie L. Graff, MD FACP FASCO @drsgraff.bsky.social · 12/06/2025
⛱️☀️📖 You have heard of “light summer beach reads” — and now @JCO_ASCO brings you “stirring, emotionally powerful, reflective narrative summer writing” (practically the same, right??) But really, what a wonderful opportunity for young writers. ✍🏻📝👨‍💻 @oncoalert.bsky.social
053
Stephanie L. Graff, MD FACP FASCO @drsgraff.bsky.social · 31/05/2025
ASCENT04 changes practice w/ improved mPFS 11.2 vs. 7.8 mos; 12 mon PFS 48 vs 33 mos w/ impressive tail suggesting potential for group with durable sustained response; adverse events were not additive. Bonus points for cr up oss over design. #ASCO25 @oncoalert.bsky.social
083
Stephanie L. Graff, MD FACP FASCO @drsgraff.bsky.social · 31/05/2025
VERITAC-2 shows vepdegestrant improves PFS after CDK4/6i among pts with HR+ mutESR1 MBc, from 2.1 months to 5.0 months. @erikahamilton9.bsky.social @oncoalert.bsky.social #ASCO25
1103
Stephanie L. Graff, MD FACP FASCO @drsgraff.bsky.social · 31/05/2025
Reflex cDNA-methylation multi-cancer early detection (MCED) test achieved meaningful per-cancer intrinsic accuracy & per-tissue of origin PPV across mult cancer types evaluated in at-risk indiv w/obesity. #ASCO25 @oncoalert.bsky.social
053
Stephanie L. Graff, MD FACP FASCO @drsgraff.bsky.social · 30/05/2025
The chemo-free combo of Ribo+Let+trastuzumab led to mOFS 30.4 months, good ORR, and minimal cardiac toxicity in this ph2 1L Korean study. #ASCO25 @oncoalert.bsky.social
172
Stephanie L. Graff, MD FACP FASCO @drsgraff.bsky.social · 30/05/2025
Dr. @hoperugo.bsky.social presents data from 5️⃣ 🇺🇸centers on re-challenge after G1 ILD with T-DXd (n=44), and a small # (n=19) G2 ILD rechallenged. 27% of G1 rechallenged had a second event; 16% of the G2 patients had a second event #ASCO25 @oncoalert.bsky.social
082
Stephanie L. Graff, MD FACP FASCO @drsgraff.bsky.social · 30/05/2025
AI-assisted training changed HER-2 low, ultra low, null classification in this analysis by Marina DeBrot et al #ASCO25
051
Stephanie L. Graff, MD FACP FASCO @drsgraff.bsky.social · 30/05/2025
Kicking off breast sessions #ASCO25 with the data that Black patients with breast cancer continue to have worse overall survival in the modern-HER2 era. Adjusted HR 1.28 @oncoalert.bsky.social
030
Reposted by Stephanie L. Graff, MD FACP FASCO
The OncoAlert Network 🚨 @oncoalert.bsky.social · 23/05/2025
The #ASCO25 #OncoAlertTOP10 Abstracts in #BreastCancer These are some of our picks of TOP abstracts we look forward to be presented at the upcoming ASCO Meeting in Chicago🇺🇸 @elisaagostinetto.bsky.social‬ @erikahamilton9.bsky.social‬ @drsgraff.bsky.social‬ @elisabettabonzano.bsky.social‬
0128
Stephanie L. Graff, MD FACP FASCO @drsgraff.bsky.social · 24/05/2025
Join me & Maryam Lustberg at #ASCO25 at #OncForum2025 to discuss ADCs, sequencing, HER2 low/ultra-low, biomarkers, and “right-sizing” early stage disease Saturday June 1 at 7:15- 7:45 PM Duneyrr Fermenta & Brewery 2337 S. Michigan Ave. Register now! app.smartsheet.com/b/form/7e557...
031
Stephanie L. Graff, MD FACP FASCO @drsgraff.bsky.social · 16/05/2025
Honored and humbled to be awarded the 2025 E. Grey Diamond Take Wing Award, my school’s highest alumni honor. Thank you, Dean Norbash, my amazing family, members of the awards committee— I am proud to embody the spirit of UMKC SOM in all that I do.
010
Stephanie L. Graff, MD FACP FASCO @drsgraff.bsky.social · 10/05/2025
In <1 minute, use @ascocancer.bsky.social link to #ProtectMedicaid. Maybe you think it isn’t about you—but sometimes patients w/cancer lose their job, insurance is tied to employment, then suddenly—Medicaid is about them. Urge members of congress to safeguard Medicaid ➡️brnw.ch/21wSxkd
030
Reposted by Stephanie L. Graff, MD FACP FASCO
American Society of Clinical Oncology @ascocancer.bsky.social · 09/05/2025
Congress is considering cuts to Medicaid during its budget reconciliation process. 70 million ppl receive health coverage under Medicaid, including those w/ cancer. We must #ProtectMedicaid! #ASCOAdvocacy Urge members of congress to safeguard Medicaid➡️ brnw.ch/21wSxGD
053
Stephanie L. Graff, MD FACP FASCO @drsgraff.bsky.social · 22/04/2025
Oncologists— The @ascocancer.bsky.social #ASCO24 #IDEA awardees are conducting a study to understand and identify barriers, opportunities, and strategies to improve evidence-based cancer care globally. Take a quick survey here: forms.office.com/pages/respon... Cc. @oncoalert.bsky.social
forms.office.com
Microsoft Forms
041
Stephanie L. Graff, MD FACP FASCO @drsgraff.bsky.social · 22/04/2025
Sacituzumab + Pembro in ASCENT04 improves Progression Free Survival in Patients With Previously Untreated PD-L1 Metastatic Triple-Negative Breast Cancer #bcsm www.gilead.com/news/news-de... @oncoalert.bsky.social
gilead.com
Trodelvy Plus Keytruda Demonstrates a Statistically Significant and Clinically Meaningful Improvement in Progression Free Survival in Patients With Previously Untreated PD L1 Metastatic Triple Negativ...
Trodelvy Plus Keytruda Demonstrates a Statistically Significant and Clinically Meaningful Improvement in Progression Free Survival in Patients With Previously Untreated PD L1 Metastatic Triple Negativ...
094
Stephanie L. Graff, MD FACP FASCO @drsgraff.bsky.social · 16/04/2025
I just had to explain the expression “burning the candle at both ends” to my 9yo. But, yep. #currentsituation
0101
Stephanie L. Graff, MD FACP FASCO @drsgraff.bsky.social · 13/04/2025
In a multivariable analysis, omitting ET was associated w/⬆️ risk of death HR 1.23; For ER 1%-5% HR 1.16; For ER 6%-10% HR 1.42 Endocrine Therapy Omission in ER–Low (1%-10%) Early-Stage Breast Cancer | @oncoalert.bsky.social ascopubs.org/doi/10.1200/...
ascopubs.org
Endocrine Therapy Omission in Estrogen Receptor–Low (1%-10%) Early-Stage Breast Cancer
PURPOSEAdjuvant endocrine therapy (ET) improves overall survival (OS) in estrogen receptor (ER)–positive early-stage breast cancer (BC). However, the benefit of ET for those with ER-low BC (ER 1%-10%)...
0115
Stephanie L. Graff, MD FACP FASCO @drsgraff.bsky.social · 12/04/2025
Check out this cool profile on all things @dramycomander.bsky.social and Lifestyle Oncology!! @oncologytimes.bsky.social journals.lww.com/oncology-tim...
journals.lww.com
The Essential Connection Between Healthy Lifestyle & Cancer ... : Oncology Times
An abstract is unavailable.
010
Stephanie L. Graff, MD FACP FASCO @drsgraff.bsky.social · 11/04/2025
REAL ID will be *really real* by #ASCO25 —make sure your ID is airport ready. ✈️ @ascocancer.bsky.social @oncbrothers.bsky.social @oncoalert.bsky.social @narjustflorezmd.bsky.social @drchoueiri.bsky.social @erikahamilton9.bsky.social @drdonsdizon.bsky.social @drteplinsky.bsky.social
033
Stephanie L. Graff, MD FACP FASCO @drsgraff.bsky.social · 10/04/2025
The act will disenfranchise vets/active/overseas military from voting as well (who often have less access to reams of documents) LDF Denounces House Passage of SAVE Act, Urges Senate to Reject Bill that Will Disenfranchise Millions of Americans - naacpldf.org/press-release/… #HellNo #VotesForVets
naacpldf.org
042
Stephanie L. Graff, MD FACP FASCO @drsgraff.bsky.social · 10/04/2025
Married women who have their husbands last name may need to show 3+ legal documents to verify voter eligibility LDF Denounces House Passage of SAVE Act, Urges Senate to Reject Bill that Will Disenfranchise Millions of Americans - #HellNo #VotesForWomen www.naacpldf.org/press-releas...
naacpldf.org
LDF Denounces House Passage of SAVE Act, Urges Senate to Reject Bill that Will Disenfranchise Millions of Americans
LDF urges the U.S. Senate to reject the misleadingly entitled “Safeguard American Voter Eligibility (SAVE) Act”, a disastrous, discriminatory, inefficient, and unnecessary bill passed by the House that would disenfranchise millions of eligible voters.
020
Stephanie L. Graff, MD FACP FASCO @drsgraff.bsky.social · 09/04/2025
This ⬇️
031
Reposted by Stephanie L. Graff, MD FACP FASCO
Victor Shi @victorshi.bsky.social · 08/04/2025
Justice Sotomayor with a bone-chilling dissent today: “The implication of the govt’s position is noncitizens AND US citizens could be taken off streets, forced onto planes, confined to foreign prisons with no opportunity for redress…This Nation's laws is designed to prevent, not en-able, their rise.
12295593071
Reposted by Stephanie L. Graff, MD FACP FASCO
SWOG Cancer Research Network @swog.org · 08/04/2025
@swog.org leaders at @ascocancer.bsky.social #ASCOAdvocacySummit 2025 in DC: Drs. Paul Hesketh, Charles Blanke, Anne Chiang, Raymond Osarogiagbon, Rafeh Naqash. Goals: - Robust federal funding for #CancerResearch, NCI, & NIH - #FixPriorAuth - #DrugShortages solutions
SWOG leaders at ASCO Advocacy Summit 2025
073
Stephanie L. Graff, MD FACP FASCO @drsgraff.bsky.social · 08/04/2025
An honor to meet w/Rep.Magaziner staff, Raisa Majid with Drs. Mega & Strenger to discuss key #ASCOAdvocacySummit asks including consistent funding for the NIH, NCI, and ARPA-H; the Improving Seniors' Timely Access to Care Act; partnering on a Solution to End Drug Shortages. @ascocancer.bsky.social
171
Stephanie L. Graff, MD FACP FASCO @drsgraff.bsky.social · 08/04/2025
Want to join us in our efforts? Visit asco.org/actnetwork to contact your Members of Congress about the issues that matter most to you! Advocates are also on the Hill to fix #PriorAuth and protect #CancerResearch funding. #ASCOAdvocacy @ascocancer.bsky.social
asco.org
Engage in ASCO's Advocacy Efforts
Write a letter to your lawmaker today!
094
Stephanie L. Graff, MD FACP FASCO @drsgraff.bsky.social · 08/04/2025
I am urging lawmakers to ensure long-term stability for oncology treatments, which will ultimately save and prolong lives. With transparency and strong manufacturing, this is preventable. #ASCOAdvocacySummit #drugshortages @ascocancer.bsky.social
051
Stephanie L. Graff, MD FACP FASCO @drsgraff.bsky.social · 08/04/2025
We ask Congress & the Administration to intervene to secure the pharmaceutical pipeline & address #drugshortages I have written guidance position⬇️ sat w/clinic pts deciding what to do when we run out of their cancer drug #ASCOAdvocacySummit @ascocancer.bsky.social 🔗 www.asco.org/practice-pat...
asco.org
Clinical Guidance - ASCO
041
Stephanie L. Graff, MD FACP FASCO @drsgraff.bsky.social · 08/04/2025
Cancer #drugshortages impact both peds& adult populations, causing treatment disruptions & delays, potentially leading to irreversible cancer progression. I am an AssocProfessor & leading cancer researcher—I know my patients, along w/all pts,deserve better #ASCOAdvocacySummit @ascocancer.bsky.social
021
Stephanie L. Graff, MD FACP FASCO @drsgraff.bsky.social · 08/04/2025
I am joining over 150 oncologists this week at the #ASCOAdvocacySummit in Washington, D.C. to urge Congress to help address existing #drugshortages and prevent future shortages of lifesaving and life-prolonging cancer drugs. @ascocancer.bsky.social
0103
Stephanie L. Graff, MD FACP FASCO @drsgraff.bsky.social · 08/04/2025
Had delightful meeting w/Sen. Whitehouse staffer Joe Page w/Drs Mega & Strenger to discuss key #ASCOAdvocacySummit key asks incld consistent funding for the NIH, NCI & ARPA-H; the Improving Seniors' Timely Access to Care Act; partnering on a Solution to End Drug Shortages @ascocancer.bsky.social
031
Stephanie L. Graff, MD FACP FASCO @drsgraff.bsky.social · 08/04/2025
ASCO CEO Cliff Hudis joined #RhodeIsland’s #ASCOAdvocacySummit delegates Drs.Mega, Strenger & I meeting w/Senator Reed Our key asks incld consistent funding for NIH, NCI & ARPA-H; the Improving Seniors' Timely Access to CareAct; partnering on a Solution to End DrugShortages @ascocancer.bsky.social
021
Stephanie L. Graff, MD FACP FASCO @drsgraff.bsky.social · 08/04/2025
An honor to meet w/ #RepGabeAmo this AM w/Drs. Mega & Strenger to discuss key #ASCOAdvocacySummit asks including consistent funding for the NIH, NCI, and ARPA-H; the Improving Seniors' Timely Access to Care Act; partnering on a Comprehensive Solution to End Drug Shortages. @ascocancer.bsky.social
021
Stephanie L. Graff, MD FACP FASCO @drsgraff.bsky.social · 07/04/2025
#RhodeIsland’s own Anthony Mega engaging with the #ASCOAdvocacySummit team around ways oncology clinicians can advocate for prior authorization reform thru Improving Seniors Timely Access to Care Act. #PriorAuth @ascocancer.bsky.social @weldeiry.bsky.social
031
Stephanie L. Graff, MD FACP FASCO @drsgraff.bsky.social · 07/04/2025
Hot tips from #ASCOAdvocacySummit #ASCOAdvocacy: A Media Interview (or high profile meeting) is the WRONG TIME for an original thought. Stay on message! Come prepared. Preach! 🙌🏻 🗣️ @ascocancer.bsky.social @lymphomadoc.bsky.social @ishwaria.bsky.social
062
Reposted by Stephanie L. Graff, MD FACP FASCO
Ida Bae Wells @nhannahjones.bsky.social · 06/04/2025
Can we get more of this? “The Japanese American National Museum will ‘scrub nothing,’ Fujioka said, and instead will highlight the importance of DEI. “Our community is based on diversity, equity is guaranteed to us in the Constitution, and inclusion is what we believe in,” Fujioka said.
latimes.com
Japanese American National Museum takes a stand against DOGE cuts to NEH
The National Endowment for the Humanities warned museums across the country that it was slashing funding, including money previously pledged to places such as LACMA and the Japanese American National ...
278285287270
Stephanie L. Graff, MD FACP FASCO @drsgraff.bsky.social · 06/04/2025
Thanks, @ASCO for naming me an Advocacy Champion for my continued commitment to advocating for issues affecting the #oncology community. You can be an Advocacy Champion too by getting involved today: asco.org/actnetwork #ASCOAdvocacySummit
0121
Stephanie L. Graff, MD FACP FASCO @drsgraff.bsky.social · 05/04/2025
Prophylaxis, clinical management, and monitoring of datopotamab deruxtecan-associated oral mucositis/stomatitis academic.oup.com/oncolo/artic... #SuppOnc #DatoDXd @hoperugo.bsky.social
academic.oup.com
Prophylaxis, clinical management, and monitoring of datopotamab deruxtecan-associated oral mucositis/stomatitis
Abstract. Oral mucositis/stomatitis (hereafter stomatitis) is a common dose-limiting toxicity seen with various classes of cancer treatment. Symptoms assoc
052
Reposted by Stephanie L. Graff, MD FACP FASCO
Virginia Schutte @vgwschutte.bsky.social · 03/04/2025
Have a laugh this morning. I dare you
16918
Stephanie L. Graff, MD FACP FASCO @drsgraff.bsky.social · 03/04/2025
Real-world risk of recurrence and treatment outcomes with adjuvant endocrine therapy in patients with stage II-III HR+/HER2- early breast cancer www.thebreastonline.com/article/S096...
thebreastonline.com
Real-world risk of recurrence and treatment outcomes with adjuvant endocrine therapy in patients with stage II-III HR+/HER2- early breast cancer
Despite adjuvant endocrine therapy (ET), recurrence is still a concern for patients with HR+/HER2- early breast cancer (EBC). We assessed recurrence risk in real-world patients with stage II/III HR+/H...
071
Stephanie L. Graff, MD FACP FASCO @drsgraff.bsky.social · 03/04/2025
Identifying surrogate endpoints as valid, reliable primary endpoints is key to advancing cancer care. Partnered on this real-world data analysis demonstrating very strong, positive correlation between iDFS and OS @acsjournalcancer.bsky.social acsjournals.onlinelibrary.wiley.com/doi/full/10....
010
Reposted by Stephanie L. Graff, MD FACP FASCO
Megan Ranney MD MPH @meganranney.bsky.social · 02/04/2025
"Fortunately for our students, Cornell is not a business. We are a university. And universities, despite rapidly escalating political, legal and financial risks, cannot afford to cede the space of public discourse and the free exchange of ideas." www.nytimes.com/2025/03/31/o...
nytimes.com
Opinion | Universities Should Not be Afraid of Contentious Ideas
Higher education cannot cede the space of public discourse and the free exchange of ideas.
518039
Reposted by Stephanie L. Graff, MD FACP FASCO
Jess Calarco @jessicacalarco.com · 02/04/2025
Booker, after speaking for more than 24 hours and breaking Thurmond's record, is still standing and still speaking--using his time to warn his colleagues and his country about the dangers of defunding universities and defunding scientific research.
Booker telling the story of his father's experience with Parkinson's and using it to speak about the importance of funding research on science and health.
343697585
Reposted by Stephanie L. Graff, MD FACP FASCO
David Corn @davidcorn.bsky.social · 02/04/2025
Corey Booker just raised the bar, concluding with a call for “good trouble.” Now his fellow Dems need to clear it—and raise it higher.
994870686
Stephanie L. Graff, MD FACP FASCO @drsgraff.bsky.social · 28/03/2025
Congratulations @pgrivasmdphd.bsky.social and so many more!! #FASCO
010
Stephanie L. Graff, MD FACP FASCO @drsgraff.bsky.social · 27/03/2025
What’s the role of PET in breast cancer? 18F-Labeled Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography in Staging and Restaging Patients With Breast Cancer | Journal of Clinical Oncology ascopubs.org/doi/full/10....
ascopubs.org
<sup>18</sup>F-Labeled Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography in Staging and Restaging Patients With Breast Cancer
1103
Stephanie L. Graff, MD FACP FASCO @drsgraff.bsky.social · 25/03/2025
Women under 40 are experiencing increased rates of breast cancer—Ocean State Stories @pellcenter.bsky.social
oceanstatestories.org
Women under 40 are experiencing increased rates of breast cancer – Ocean State Stories
Two Rhode Island women and their doctors share their stories NEWPORT – Two years after she learned she had...
030
Reposted by Stephanie L. Graff, MD FACP FASCO
Stephanie L. Graff, MD FACP FASCO @drsgraff.bsky.social · 26/02/2025
Now our breast medical oncology job is posted as well— Our team is GROWING!! 🥳🎆 Come be a part of the fun! Bring the whole crew! #jobalert #oncsky careercenter.asco.org/job/7623746/...
careercenter.asco.org
Medical Oncologist - Providence, Rhode Island (US) job with Brown University/Rhode Island Hospital | 7623746
Brown University Health is seeking a medical oncologist specializing in breast cancer.
041